A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus
暂无分享,去创建一个
Yan Zhang | Chengyu Jiang | Zhendong Zhao | Xiaojun Xu | Wei Wang | Jincun Zhao | Xiaojun Xu | Chengyu Jiang | P. Lv | Yan Zhang | Jincun Zhao | Zhihong Yuan | Rujing Jia | Ping Lv | Xiao-Ming Gao | Zhen-dong Zhao | Xiao-ming Gao | Rujing Jia | Wei Wang | Z. Yuan
[1] S. Harrison,et al. Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.
[2] Ruifu Yang,et al. Antigenicity Analysis of Different Regions of the Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein , 2004, Clinical chemistry.
[3] Wenhui Li,et al. A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2* , 2004, Journal of Biological Chemistry.
[4] Xiaolei Yin,et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. , 2004, The Journal of infectious diseases.
[5] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.
[6] Shibo Jiang,et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine , 2004, Biochemical and Biophysical Research Communications.
[7] C. Nardella,et al. Mechanism of activation of human heparanase investigated by protein engineering. , 2004, Biochemistry.
[8] Hongbo Hu,et al. Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library. , 2005, Journal of combinatorial chemistry.
[9] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.
[10] Jincun Zhao,et al. Prokaryotic expression, refolding, and purification of fragment 450–650 of the spike protein of SARS-coronavirus , 2004, Protein Expression and Purification.
[11] Yanjun Zhou,et al. Identification and antigenic epitope mapping of immunodominant region amino residues 510 to 672 on the spike protein of the severe acute respiratory syndrome coronavirus. , 2005, DNA and cell biology.
[12] T. Ho,et al. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein , 2003, Biochemical and Biophysical Research Communications.
[13] Shibo Jiang,et al. Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies , 2005, The Journal of Immunology.
[14] Weihong Jiang,et al. Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential , 2005, FEBS Letters.
[15] Huanming Yang,et al. Assessment of Immunoreactive Synthetic Peptides from the Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus , 2003, Clinical chemistry.
[16] Yanjun Zhou,et al. Identification of two antigenic epitopes on SARS-CoV spike protein , 2004, Biochemical and Biophysical Research Communications.
[17] Xiaolei Yin,et al. Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing Antibodies , 2004, Journal of Virology.
[18] D. Dimitrov,et al. Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain , 2004, Biochemical and Biophysical Research Communications.
[19] Christian Drosten,et al. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.
[20] C Kaether,et al. Green fluorescent protein: applications in cell biology , 1996, FEBS letters.
[21] Ying-hua Chen,et al. Predefined spacers between epitopes on a recombinant epitope-peptide impacted epitope-specific antibody response. , 2005, Immunology letters.
[22] Obi L. Griffith,et al. The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.
[23] Jincun Zhao,et al. Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus , 2004, Journal of Clinical Virology.
[24] Y. Guan,et al. Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.
[25] Wenhui Li,et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Bernini,et al. Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein , 2003, Biochemical and Biophysical Research Communications.